A Randomized Encouragement Trial to Increase Mail Order Pharmacy Use and Medication Adherence in Patients with Diabetes
Autor: | Julie A. Schmittdiel, Wendy Dyer, Bharathi Ramachandran, Dennis Ross-Degnan, J. Frank Wharam, Deanne Wiley, Cassondra Marshall, Romain Neugebauer, O. Kenrik Duru, Susan D. Brown, Andrew J. Karter, Connie Mah Trinacty |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Clinical Trials and Supportive Activities Clinical Sciences Psychological intervention Pharmacy 01 natural sciences Hawaii Medication Adherence encouragement trial 03 medical and health sciences 0302 clinical medicine 7.1 Individual care needs Clinical Research General & Internal Medicine Diabetes mellitus Internal medicine Intervention (counseling) Behavioral and Social Science Health care Diabetes Mellitus Internal Medicine medicine Humans Postal Service 030212 general & internal medicine 0101 mathematics Metabolic and endocrine Original Research mail order pharmacy diabetes business.industry Telephone call 010102 general mathematics Health Services medicine.disease Metformin Outreach Good Health and Well Being Management of diseases and conditions business medicine.drug |
Zdroj: | J Gen Intern Med Journal of general internal medicine, vol 36, iss 1 |
ISSN: | 1525-1497 0884-8734 |
DOI: | 10.1007/s11606-020-06237-8 |
Popis: | BACKGROUND: Mail order pharmacy (MOP) use has been linked to improved medication adherence and health outcomes among patients with diabetes. However, no large-scale intervention studies have assessed the effect of encouraging MOP use on medication adherence. OBJECTIVE: To assess an intervention to encourage MOP services to increase its use and medication adherence. DESIGN: Randomized encouragement trial. PATIENTS: 63,012 diabetes patients from three health care systems: Kaiser Permanente Northern California (KPNC), Kaiser Permanente Hawaii (KPHI), and Harvard Pilgrim Health Care (HPHC) who were poorly adherent to at least one class of cardiometabolic medications and had not used MOP in the prior 12 months. INTERVENTION: Patients were randomized to receive either usual care (control arm) or outreach encouraging MOP use consisting of a mailed letter, secure email message, and automated telephone call outlining the potential benefits of MOP use (intervention arm). HPHC intervention patients received the letter only. MEASUREMENTS: We compared the percentages of patients that began using MOP and that became adherent to cardiometabolic medication classes during a 12-month follow-up period. We also conducted a race/ethnicity-stratified analysis. RESULTS: During follow-up, 10.6% of intervention patients began using MOP vs. 9.3% of controls (p |
Databáze: | OpenAIRE |
Externí odkaz: |